Compounds that selectively negatively modulate NMDA receptors containing an NR1/NR2B subunit, pharmaceutical compositions comprising the compounds, and methods of treating a disease using the compounds are disclosed.
本研究公开了选择性负调节含有 NR1/NR2B 亚基的 N
MDA 受体的化合物、包含这些化合物的药物组合物以及使用这些化合物治疗疾病的方法。